Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue May 2015
 •  Palmers Casts Hewitt for Fall Campaign  •  UPDATE: P&G Sells Frédéric Fekkai  •  Novex Expands With Curls Collection  •  Net-A-Porter Picks Up Goldfaden MD  •  Spectrum Buys Armor All
Print

P&G Patents Topical Oral Care Composition



Published November 6, 2012
Related Searches: care active latin award
Post a comment

US Patent No. 8,277,782 B2; Procter & Gamble has been awarded patent coverage for a topical oral care composition for controlling oral cavity bacterial infection and reducing risk of developing an oral bacteria-induced systemic disease in humans and other animal subjects. The composition consists of a safe and effective amount of a combination of antioxidant and H2-antagonist host-response modulating agents, wherein the antioxidant is selected from one or a mixture of gallic acid, N-acetyl cysteine, or anethole dithiolthione and the H2-antagonist is selected from one or a mixture of cimetidine, etintidine, ranitidine, tiotidine, lupitidine, donetidine, famotidine, roxatidine, pifatidine, lamtidine, zaltidine, nizatidine, mifentidine, ramixotidine, loxtidine, bisfentidine, sufotidine, ebrotidine or impromidine; a safe and effective amount of an additional oral therapeutic active selected from one or a mixture of antimicrobial/antiplaque agents selected from benzalkonium chloride, salicylanilide, domiphen bromide, cetylpyridinium chloride, tetradecylpyridinium chloride and N-tetradecyl-4-ethylpyridinium chloride; and a pharmaceutically-acceptable oral carrier.


blog comments powered by Disqus